Article Text

PDF
Darwin and the survival of the fittest in modern interventional cardiology
  1. V K Bhatia,
  2. C Di Mario
  1. Department of Interventional Cardiology, The Royal Brompton Hospital, London, UK
  1. Correspondence to:
    Professor Carlo Di Mario
    Department of Interventional Cardiology, The Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK; c.dimario{at}rbh.nthames.nhs.uk

Abstract

The diabetic patient requires a full armamentarium of proven and developing treatments in order to minimise periprocedural risk as well as improve long term outcome

  • DES, drug eluting stents
  • Gp, glycoprotein
  • MACE, major adverse cardiac events
  • MI, myocardial infarction
  • PCI, percutaneous coronary intervention
  • TLR, target lesion revascularisation
  • diabetes mellitus
  • glycoprotein IIb/IIIa
  • percutaneous coronary intervention
  • drug-eluting stent

Statistics from Altmetric.com

Footnotes

  • Published Online First 31 January 2006

  • Conflict of interest: none.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.